Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bioscience Animal Health PCL's total inventories for the quarter that ended in Jun. 2026 was ฿309 Mil. Bioscience Animal Health PCL's average total inventories from the quarter that ended in Mar. 2026 to the quarter that ended in Jun. 2026 was ฿276 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Bioscience Animal Health PCL's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was ฿0.96.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Bioscience Animal Health PCL's Days Inventory for the
three
months ended in Jun. 2026 was 50.95.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bioscience Animal Health PCL's Inventory Turnover for the quarter that ended in Jun. 2026 was 1.79.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bioscience Animal Health PCL's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.48.
Bioscience Animal Health PCL (BKK:BIS) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Bioscience Animal Health PCL's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bioscience Animal Health PCL's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Bioscience Animal Health PCL Total Inventories Related Terms
Bioscience Animal Health PCL Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioscience Animal Health PCL Total Inventories Chart
Bioscience Animal Health PCL Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Bioscience Animal Health PCL (BKK:BIS) has a Total Inventories of ฿309 Mil as of Jun. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Bioscience Animal Health PCL and its competitors.
Is Bioscience Animal Health PCL's Total Inventories too high?
Bioscience Animal Health PCL's current Total Inventories is ฿309 Mil. Overall, Bioscience Animal Health PCL has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioscience Animal Health PCL's Total Inventories compare to KHC and GIS?
Bioscience Animal Health PCL's Total Inventories of ฿309 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Consumer Packaged Goods company?
A good Total Inventories depends on the Consumer Packaged Goods industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Bioscience Animal Health PCL and its competitors. Bioscience Animal Health PCL's current Total Inventories is ฿309 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioscience Animal Health PCL stock overvalued right now?
Based on GuruFocus' analysis, Bioscience Animal Health PCL (BKK:BIS) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿2.62, compared to a current price of ฿2.20 — trading 16% below its estimated fair value. The current Total Inventories is ฿309 Mil. Bioscience Animal Health PCL's overall GF Score™ is 83/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Bioscience Animal Health PCL (BKK:BIS), the current Total Inventories is ฿309 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioscience Animal Health PCL (BKK:BIS) Overvalued in 2026?
Based on GuruFocus' analysis, Bioscience Animal Health PCL stock appears to be undervalued.
The current stock price of ฿2.20 is trading 16% below its estimated GF Value™ of ฿2.62.
GuruFocus considers Bioscience Animal Health PCL to be Modestly Undervalued.
Key valuation signals for BKK:BIS:
Total Inventories: ฿309 Mil
GF Value™: ฿2.62 vs. price of ฿2.20 (16% below fair value)
No single metric tells the full story. See the BKK:BIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioscience Animal Health PCL along with its subsidiaries is engaged in the manufacturing, import and distribution of pharmaceutical supplies, medical devices, equipment and products for livestock and companion animals (pets). Geographically, the company generates revenue from Thailand, and also has presence in other countries.
83GF Score
Get the complete analysis for BKK:BIS
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BIS has been successfully added to your 
